Women using fertility drugs who did not conceive a 10-plus week pregnancy were at a statistically significant reduced risk of breast cancer compared to nonusers; however, women using the drugs who…

A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro. The findings, published in the…

A simple and cost effective imaging device for breast tumor detection based on a flexible and wearable antenna system has been developed by researchers at the Indiana University – Purdue University Indianapolis.…

Accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS), a very common early stage and noninvasive form of breast cancer, meaning many…

A new analysis has found that physical activity – either mild or intense and before or after menopause – may reduce breast cancer risk, but substantial weight…

European regulators on Friday recommended approval of a Novartis’ for the treatment of advanced breast cancer.

The Committee for Medicinal Products for Human Use (CHMP) issued a positive recommendation…

A top British doctor commissioned by the U.K. government says faulty French-made breast implants by Poly Implant Prothese do not pose any long-term health problems to…

Certain short strands of RNA, known as microRNAs (miRNAs), have been linked to the progression and metastasis of breast cancer and may provide information about prognosis.…

Should women stop drinking alcohol altogether? Not quite, but maybe they should stop after that first drink.

A new study by the National Cancer Institute of 1,900 post-menopausal women found that…

Houston researchers on Wednesday reported positive results with an experimental breast cancer vaccine, a promising development in an emerging field in cancer care.

The vaccine, one of many now in…

An experimental drug designed to treat patients with a specific kind of breast cancer known as HER2-positive appeared to boost survival compared to the standard treatment, a new study…

Doctors have successfully dropped the first “smart bomb” on breast cancer, using a drug to deliver a toxic payload to tumor cells while leaving healthy ones alone.

In a key test…

A novel form of trastuzumab (Herceptin) with chemotherapy attached appears to improve progression-free survival (PFS) in advanced HER2-positive breast cancer with a hint of survival benefit as well, a pivotal clinical…

Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is…

Women who regularly work into the early hours can be nearly four times as likely to develop breast cancer, scientist have warned.

The risk is highest among women who…

Interim results from a mid-stage trial of Celldex Therapeutics Inc’s experimental drug showed trends toward reducing tumors in patients with advanced breast cancer, with rates improving for those patients…

Magnetic resonance imaging (MRI) provides an indication of a breast tumor’s response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online in…

Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms…

Millions of middle-aged women were needlessly denied HRT because a landmark report which found it raised the risk of breast cancer was exaggerated, while the benefits to middle-aged women were…

New research suggests that weight loss through exercise and dieting helps overweight women lower the levels of certain hormones in their blood, potentially raising the odds that they’ll…

Multiple research projects – including a 2006 study conducted at the University of North Carolina at Chapel Hill – have used DNA microarray analysis to identify several…

Even a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of…

The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central’s open access journal Breast Cancer Research.…

A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and…

In two back-to-back reports published online on 17 May in Cell, researchers have sequenced the genomes of 21 breast cancers and analysed the mutations that emerged during the tumours’ development. The…